UK markets close in 3 hours 1 minute

BerGenBio ASA (0RU5.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
0.1595-0.0003 (-0.16%)
As of 06:03PM BST. Market open.
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-96.04%
S&P500 52-week change 322.64%
52-week high 35.3000
52-week low 30.0000
50-day moving average 30.2624
200-day moving average 30.5130

Share statistics

Avg vol (3-month) 3238.76k
Avg vol (10-day) 3133.58k
Shares outstanding 554.71M
Implied shares outstanding 6N/A
Float 81.75B
% held by insiders 145.30%
% held by institutions 113.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-12,300.57%

Management effectiveness

Return on assets (ttm)-70.31%
Return on equity (ttm)-176.32%

Income statement

Revenue (ttm)354k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-9.00%
Gross profit (ttm)N/A
EBITDA -191.6M
Net income avi to common (ttm)-190.4M
Diluted EPS (ttm)-3.5040
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)156.42M
Total cash per share (mrq)0.06
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.71
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-225.1M
Levered free cash flow (ttm)-156.72M